News Focus
News Focus
icon url

CJames22

04/20/21 4:40 PM

#28267 RE: jb128 #28266

Why should we be shocked? They finished the 1.b) portion and decided to terminate the agreement and open Lenzilumab up to the broader CAR-T market. Maybe I'm in the wrong but it seems some people are reading into this too much (similar to the mITT/ITT fiasco)